| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-17 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |